MetLife Inc. (NYSE:MET) at last check was buoying at $65.86 on Friday, September 15, with a fall of -0.11% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $65.93 with its price kept floating in the range of $64.7321 and $65.97 on the day. Company’s P/E ratio for the trailing 12 months is 30.14. Considering stock’s 52-week price range provides that MET hit a high price of $77.36 and saw its price falling to a low level of $48.95 during that period. Over a period of past 1-month, stock came adding 6.81% in its value.
With its current market valuation of $49.11 billion. MET Stock’s Forward Dividend of 2.08 and its yield of 3.16% are making investors’ thoughts stronger that it could climb further before the company announces its earnings for the current quarter. Analysts are in estimates of $2.09 per share for company’s earnings in the current quarter and are expecting its annual EPS growth moving up to $7.7 for 2023 with estimates of that growing to $9.26 in next year. These estimates are suggesting current year growth of 12.40% for EPS and 20.30% growth next year.
Analysts watching the company’s growth closely have provided estimates for its revenue growth with an average revenue estimate of $17.7 billion. They suggested that in the process company could generate revenue of as low as $16.57 billion which could climb up to $18.59 billion to hit a high. The average estimate is representing a decrease of -25.30% in sales growth from that of posted by the company in the same quarter of last year. In keeping analyst consensus estimate with, company is forecasted to be making an annual revenue of $70.33 billion in 2023, which will be -6.90% less from revenue generated by the company last year.
In last 7 days, analysts came adjusting their opinions about stock’s EPS with no upward and no downward revisions, an indication which could give clearer idea about the company’s short term price movement. In contrast, when we review MET stock’s current outlook then short term indicators are assigning it an average of 100% Buy, while medium term indicators are categorizing the stock at an average of 50% Buy. Long term indicators are suggesting an average of 50% Buy for it.
Digging deeper we become aware of the PEG ratio of the MET stock which is currently positioned at 3.21. It further provides that stock’s current price level is 4.55% away from its 20-day simple moving average and is 6.25% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 69.13 while volatility remained at 1.71% over the past week which changes to 1.60% when measuring it over the past month. Beta is valued at 1.09, while measure of average true range or ATR is currently at 1.12. In predicting price targets of as low as $69.00 and as high as $85.00, analysts are in agreement on assigning the stock over the next 12 months average price target of $77.96. Stock’s current price level is -4.77% above from estimated low price target while it is -29.06% below the estimated high; and even if the MET’s share succeeded to reach the median price of $79.50, then the outlook of -20.71% could come to the excitement of the investors.
In comparing MetLife Inc. (MET)’s stock with other industry players reveals that stock’s latest price change of -0.11% and that of -0.83% over the past 12 months is in competing position with that of Autoliv Inc. (ALV) which saw its stock price raised by 0.39% in the recent trading and went through an increase of 28.63% in past 12-month trading. Industry’s another major player The Cigna Group (CI) has rise 0.35% up in latest trading session, but over the past year has faced arise of 0.07% over the same period. MetLife Inc. has a P/E ratio of 30.14 against that of Autoliv Inc.’s 21.54 while The Cigna Group is showing 12.95 for the same. On the other hand, the S&P 500 Index is down -0.88% in the early deals today while the Dow Jones Industrial was dealinglower at -0.58%.
Having a second look at MetLife Inc. (NYSE:MET) provides that stock’s average daily trading volume for 3 months was 3.93 million, while it jumped to 3.6 million when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 765.90 million.
The percentage of outstanding shares held by the insiders is 0.10% while it is 75.50% for the institutional holders. The figures also indicate that as of Aug 30, 2023, number of stock’s short shares was 9.26 million which implies a short ratio of 2.74. This shows down a 1.23% of Short Interest in company’s outstanding shares on the day. In August the standing of shares short improved as it was 9.31 million in the previous month. Subtraction of -9.00% by stock’s current price to its year-to-date value in today’s trading is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.